• FirefoxInstall the new Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.42%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    2.01 Down 0.12(5.63%) 4:00PM EDT
    Add to Portfolio
    Prev Close:2.13
    Open:2.04
    Bid:N/A
    Ask:3.08 x 1500
    1y Target Est:2.00
    Beta:1.15
    Next Earnings Date:N/A
    Day's Range:2.01 - 2.15
    52wk Range:0.39 - 3.47
    Volume:69,797
    Avg Vol (3m):77,018
    Market Cap:25.39M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECTE

    Comparison

    Symbol% ChgMkt Cap
    ECTEDown 5.63%25.39M
    ABTDown 0.95%69.25B
    DXCMDown 1.36%4.77B
    MDTDown 2.37%74.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,559.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback